The research focuses on the identification and validation of non-invasive biomarkers for the early detection of cancer for use in secondary prevention. For example, a blood test for the early detection of mesothelioma has been successfully developed. Furthermore, the mechanisms of carcinogenesis because of the effects of pollutants are being researched. The use of the latest molecular methods is used to determine the changes in genetic material and its regulation in occupational tumors. New analysis methods are being developed for the minimally invasive diagnosis of early-stage tumors, to be able to examine even the smallest sample quantities.
The results of the MoMar study are now going to be implemented in a follow-up care program. The “Extended Screening Program for the Early Detection of Mesothelioma” (EVA-Mesothel) is to be offered nationwide at the end of its current pilot phase.
